ImmunoCellular Therapeutics, Ltd announced the presentation of updated immune monitoring data from the phase 2 trial of ICT-107 in patients...
Read moreSanofi announced that the U.S. FDA approved once-daily Soliqua 100/33 100 Units/mL & 33 mcg/mL for the treatment of adults...
Read moreSandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...
Read moreTeva Pharmaceutical Industries Ltd announced it has obtained approval from the European Commission for an indication extension of Trisenox® (arsenic...
Read morePharmAkea Inc. announced the extension of their strategic collaboration with Celgene Corporation which was established to leverage PharmAkea's proprietary drug...
Read moreEli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the...
Read moreAmgen and Daiichi Sankyo Company announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal...
Read moreSpark Therapeutics and Pfizer Inc announced that the U.S. FDA has granted breakthrough therapy designation to SPK-9001, the lead investigational...
Read moreAstraZeneca announced that the EC has approved Qtern tablets for the treatment of type 2 diabetes in all 28 EU...
Read moreAstraZeneca announced that the Phase III AURA3 trial met its primary endpoint, demonstrating superior progression-free survival (PFS) compared to standard...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
